Abstract
Polycystic ovary syndrome (PCOS) affects up to 10% of women of reproductive age and often presents with cutaneous manifestations of hyperandrogenism, including acne, hirsutism, and androgenic alopecia.1 Barbieri et al2 showed superior long-term drug use survival with spironolactone versus oral antibiotics in patients with acne. We present our experience using spironolactone to treat acne in a multidisciplinary PCOS clinic at an academic tertiary care center.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
